T-helper 17 cytokines expression in leprosy skin lesions

British Journal of Dermatology

Volumn 173, Issue 2, 2015, Pages 565-567

  Quaresma, J A S ^a,b   Aarao T L S ^a,b   Sousa, J R ^a   Botelho, B S ^a   Barros, L F ^b   Araujo, R S ^b   Rodrigues, J L P ^b   Prudente, D L ^b   Pinto, D S ^a   Carneiro, F R O ^b   Fuzii, H T ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

BORDERLINE LEPROSY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LEPROMATOUS LEPROSY; LEPROSY; LETTER; MACROPHAGE ACTIVATION; MADRID CLASSIFICATION; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN BIOPSY; SKIN DEFECT; T LYMPHOCYTE ACTIVATION; TH17 CELL; TUBERCULOID LEPROSY; BACTERIAL SKIN DISEASE; CROSS-SECTIONAL STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM;

CROSS-SECTIONAL STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; LEPROSY; SKIN DISEASES, BACTERIAL; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941177095     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13608     Document Type: Letter

References (14)

1. Romagnani S,. Human Th17 cells. Arthritis Res Ther 2008; 10: 206-8.
2. Moissec P, Korn T, Kuchroo V,. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-98.
3. Goulart IM, Penna GO, Cunha G,. Immunopathology of leprosy: the complexity of the mechanisms of host immune response to Mycobacterium leprae. Rev Soc Bras Med Trop 2002; 35: 365-75.
4. Hsu SM, Raine L, Fanger H,. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
5. Scollard DM, Adams LB, Gillis TP, et al,. The continuing challenges of leprosy. Clin Microbiol Rev 2006; 19: 338-81.
6. Mangan PR, Harrington LE, O'Quinn DB, et al,. Transforming growth factor-β induces development of the Th17 lineage. Nature 2006; 441: 231-4.
7. Quaresma JAS, Oliveira MF, Guimarães ACR, et al,. CD1a and FXIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection. Am J Dermatopathol 2009; 31: 527-31.
8. Kimura A, Naka T, Kishimoto T,. IL-6-dependent and independent pathway in the development of interleukin 17-producing T helper cells. PNAS 2007; 104: 12099-104.
9. Deenick EK, Tangye SG,. IL-21: a new player in Th17-cell differentiation. Immunol Cell Biol 2007; 85: 503-55.
10. Scriba TJ, Kalsdorf B, Abrahams D,. Distinct specific IL-17 and IL-12 producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008; 180: 1962-70.
11. Betelli E, Carrier Y, Gao W, et al,. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006; 441: 235-8.
12. Saini C, Ramesh V, Nath I,. CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, non Th2 T cells in human leprosy. PLoS Negl Trop Dis 2013; 7: e2338.
13. Fischer MK, Myer KA, Que SK, et al,. Pseudoepitheliomatous hyperplasia and transepidermal elimination in lepromatous leprosy: does T-cell plasticity play a role? J Drugs Dermatol 2012; 11: 1232-5.
14. Stefani MM, Guerra JG, Sousa AL, et al,. Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report. BMC Infect Dis 2009; 9: 75-82.